Orgaran 750 anti-factor Xa units solution for injection,
Danaparoid sodium
1. What Orgaran is and what it is used for
2. Before you use Orgaran
3. How to use Orgaran
4. Possible side effects
5. How to store Orgaran
6. Further information
Orgaran solution for injection contains danaparoid sodium and is one of a group of medicines that are called antithrombotics.
Orgaron is used to prevent blood clots from forming in the blood-vessels and is used in patients who have an increased chance of getting a blood clot (for example in patients who are bedridden and have had surgery).
Orgaran can also be used to prevent or treat blood clots in patients who can no longer be given heparin because they have a condition called heparin induced thrombocytopenia (a large drop in the number of platelets due to hypersensitivity to heparin).
if you are being given heparin (a frequently used antithrombotic) to treat blood clots you should not have a spinal or epidural anesthetic for surgery.
Medicines which may increase the risk of bleedings when taken at the same time as Orgaran:
Food and drinks are not known to have effects on the effectiveness of Orgaran.
Orgaran is not known to have any effect on the ability to drive and use machines.
Orgaran contains sodium sulfite E221. Tell your doctor if you have ever had hypersensitivity to sulfite, as this can cause severe allergic reactions in asthma patients.
Orgaran is injected by a doctor or nurse
The dose for the prevention of blot clots is 1 ampoule (750 units), twice-a-day, for up to 14 days. Sometimes you may be given Orgaran for longer than this. Patients with a large drop in the number of blood platelets during heparin administration (thrombocytopenia, see Section 1) usually need higher doses.
Your doctor will work out the dose of Orgaran you need based on:
Orgaran may be given to children. Your doctor will take into account age and weight to determine to dose.
Orgaran will be given to you by a doctor or nurse. Orgaran is given either as an injection under the skin or as an injection into a vein.
As your doctor or nurse will be monitoring your condition carefully it is unlikely that you will be given too much Orgaran and, when needed, they will adjust doses.
If too high a dose is given you may notice unusual bleeding. This may show by:
As your doctor and nurse carefully check your medical condition, it is unlikely that you will receive too low a dose Orgaran. If needed, they will adjust the dose.
Your doctor will decide when to stop Orgaran use.
If you have any further questions on the use of this product, ask your doctor.
Like all medicines, Orgaran can cause side effects, although not everybody gets them.
Orgaran may increase the risk of bleeding.
Some side effects are more common than others:
Common side effects
(less than 1 in 10, but more than 10 out of 100 patients given Orgaran)
Uncommon side effects
(less than 1 in 100, but more than 1 out of 1000 patients given Orgaran)
Rare side effects
(less than 1 in 1000 patients given Orgaran)
If any of the side effects gets serious,
or if you notice any side effects not listed in this leaflet
When heparin (an antithrombotic) is used at the same time as a spinal injection, bruising of the spine may occur. This occurs very rarely and not necessarily with Orgaran (see section 2).
However, if you notice any of the following symptoms:
The hospital will keep Orgaran according to the correct storage conditions.
Keep out of the reach and sight of children.
Do not store above 30 °C. Do not freeze.
Do not use if the solution contains particles.
Store in the original package in order to protect from light.
Do not use Orgaran after the expiry date which is stated on the carton after “exp”. The expiry date refers to the last date of that month.
Orgaran is a clear, colourless to pale yellow solution for injection.
It is available in glass ampoules (either 10 or 20 per box). Each ampoule contains 0.6 mL solution with 750 anti-factor Xa units danaparoid sodium.
Not all pack sizes may be marketed.
Marketing Authorisation Holder:
Manufacturer: